RECENT NEWS
BD to split out Biosciences and Diagnostic Solutions business
BD (Becton, Dickinson and Company) has announced a plan to separate BD's Biosciences and Diagnostic Solutions business from the rest of the company.
Novel blood test accurately detects detect colorectal cancer and polyps
Precision medicine firm Oxford BioDynamics has announced the publication of compelling results involving its technology in a multi-centre study using blood to detect colorectal cancer (CRC), including early stage, and non-cancerous polyps with high accuracy.
FMS acquired by Trescal
Facility Monitoring Systems (FMS), a trusted provider of contamination control solutions, is excited to announce that it has joined Trescal, a global leader in calibration services.
A milestone reached in Bristol for the LIAISON XL
Severn Pathology in Bristol has recently gone live with its fourth LIAISON XL system. What makes this one a bit more special is that it marks production of Diasorin’s 7,000th LIAISON XL instrument.
Novel diagnostic could help prevent unnecessary thyroid surgeries
A new diagnostic test being trialled across eight NHS hospitals could transform how thyroid lumps are assessed, potentially sparing hundreds of patients from unnecessary surgery.
IBMS launches biggest Congress yet
The Institute of Biomedical Science (IBMS) has officially launched Congress 2025, which it says will be its most comprehensive yet, featuring diverse education, cutting-edge exhibitions, and unparalleled networking opportunities.
NHS opens new mpox vaccination sites
Twelve new mpox vaccination sites have opened across England, making it easier for eligible people to get protected.
Consultation launched on regulating cancer vaccines
The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a consultation on regulatory guidance for individualised mRNA cancer immunotherapies (colloquially referred to as cancer vaccines).
New NHS guidance focusses on efficiencies and faster treatment
The NHS will focus on delivering faster treatment for hundreds of thousands of patients – including for planned surgeries and emergency care – as the number of national targets is almost halved under new guidance to reform services.
UK-wide study into dementia blood tests launches
A major new study aimed at identifying blood tests that could help diagnose dementia more accurately and quickly than current methods has begun recruiting patients from January 2025.
UKHSA publishes updated AMR tool
The UK Health Security Agency (UKHSA) has published an updated antimicrobial stewardship tool to support healthcare professionals across the UK prescribe the most appropriate antibiotics for patients, while protecting against antimicrobial resistance (AMR).
UKHSA launches new metagenomic surveillance for health security
The UK Health Security Agency (UKHSA) has launched a world-first metagenomics initiative to aid in the rapid detection of infectious diseases that could threaten the UK.
POCT Innovators event – breaking through adoption barriers
The next POCT Innovators event, ‘Clinical Innovations EXPO – Breaking Through the Adoption Barriers’ will take place Thursday 15 May in Nottingham.
Genomic test predicts bowel cancer risk in people with IBD
A new genomic test can identify which people with inflammatory bowel disease (IBD) have the highest risk of bowel cancer, according to a new study by Cancer Research UK scientists working at the Institute of Cancer Research (ICR) in London.
Developing regulatory science to advance healthcare
Innovate UK, in partnership with the Medicines and Healthcare products Regulatory Agency (MHRA), Office for Life Sciences and the Medical Research Council (MRC), has announced seven new Centres of Excellence for Regulatory Science and Innovation (CERSIs) to help drive advancements in healthcare.
FDA Breakthrough Device Designation for Beckman Coulter’s Alzheimer's blood test
Beckman Coulter Diagnostics has announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Beckman Coulter's Access p‑Tau217/β-Amyloid 1-42 plasma ratio. This blood test is designed to aid healthcare providers identify patients with amyloid pathology associated with Alzheimer's disease.
Diasorin welcomes new Sales Manager for Ireland
Diasorin is pleased to welcome Tom Attride as the new Area Sales Manager for the Republic of Ireland and Northern Ireland.
RCPath launches new Workforce Strategy
The Royal College of Pathologists (RCPath) has launched its first dedicated Workforce Strategy that advocates for pathology services that are fit for the future.
NHS introduces genetic test to reduce risk of donor kidney failure
Hundreds of potential kidney donors of Black African and Black Caribbean heritage can now get a simple blood test through the NHS to help reduce the risk of kidney failure.
Leadership changes at UKHSA
Dame Jenny Harries has announced she will step down as UK Health Security Agency’s Chief Executive in early summer.
Latest Issues
HORIBA Medical is a renowned specialist in the design and manufacture of automated in-vitro diagnostic systems for analysis in haematology, clinical chemistry, and haemostasis. From compact point of care (POC) solutions to high throughput laboratory systems, HORIBA Medical has successfully developed an array of analysers and data management...
Run 15 Variant Classification and Clinical Impact of Variability - webinar
Online
16 September, 2025
GenQA at ESCV 2025
Thessaloniki Concert Hall
17 September, 2025
International nomenclature for genomics for complex numerical and structural abnormalities - webinar
Online
18 September, 2025
IBMS Congress
The International Convention Centre (ICC), Birmingham
22-25 September, 2025
Diagnostics North East Conference 2025
The Catalyst, Newcastle
3 October